2023 Annual Report Highlights
THE END OF CANCER BEGINS WITH RESEARCH
To open our 2023 Annual Report, we must first acknowledge and thank the incredible people that make Kure It a success. Our staff, Board of Directors, Medical Advisory Board and Women’s Guild do an amazing job helping us achieve our goals. But most of all, we must thank all our generous donors. Without your continued support for Kure It, we would not be able to fund the innovative research that helps us move closer to finding cures for these terrible diseases. We are truly grateful for this dedicated team and community that perpetuate Kure It’s accomplishments.
Together we can save lives!
2023 Vision
Prevention Detection Treatment
Three words that can change the trajectory of a cancer diagnosis.
As Kure It celebrates its sixteenth year raising funds for research and working closely with cancer centers across the US; we will also shed some light on current prevention opportunities, early detection and screening protocols, and best treatment options possible.
Working closely with our Board of Directors and Medical Advisory Board, Kure It will continue to grant the best and brightest in cancer research, while spotlighting opportunities to share cancer prevention updates and the importance of early screening, reaching out to communities, and sharing our common mission regarding health and wellness.
Outreach
Our goal for 2023 is to build on the tremendous corporate and personal relationships we have, while outreaching to new, diverse partners that share our core belief that cancer is curable.
By opening the cancer conversation and creating a safe space to learn and collaborate, Kure It will utilize new opportunities to create impactful programs and initiatives that support our values and partnerships.
​
Connecting those with like-minded goals and desires to kick cancer to the curb, once and for all!
Impact
To address the needs for underfunded cancer research, Kure It partners with the self-storage industry to raise money through a program called Round Up For Research.
Round Up offers recurring passive income that supports Kure Its overhead and assists with research grants.
Expanding Round Up in 2023 offers new opportunities to make meaningful financial contributions to the Comprehensive Cancer Centers we support.
2024 Highlights
Kure It had another impactful year in 2024. As we celebrated another year of fighting for a cure, we saw an overwhelming outpouring of generosity from our donors. We surpassed the milestone of $17,500,000 raised since our inception and funded six new cancer research projects. Although it seemed like each month brought an experience worth noting, we’d like to share a couple of the year’s biggest standouts.
In May, Kure It was once again named the charity of choice and recipient of the proceeds from the California Self Storage Association’s Napa Owners Conference’s Charity Golf Classic. After working with the committee for months leading up to the event, the CSSA was able to sell out the tournament for the first time since its inception in 2018. With a full field of golfers, along with an online silent auction added this year, the tournament was able to raise over $68,000 for Kure It. These funds have been set aside to award another named research grant in the CSSA’s members’ honor.
THE END OF CANCER BEGINS WITH RESEARCH
2022 GRANTS
Foundational Funding
City Of Hope
Name of Research Foundation Funded:
Southern California Genitourinary Cancer Research Collaborative
$107,500 Awarded to
Rivals United
Grant
JinSeok Park, Ph.D
Name of Research Project:
Metastatic Invasion of Fusion-positive Rhabdomyosarcoma Regulated by Intratumoral Heterogeneity” in relation to Pediatric cancer (rhabdomyosarcom).
$100,000 Awarded to
Terry Donahue
Memorial Grant
Mustafa Raoof, MD, MS, FACS
Name of Research Project:
Integrated characterization of cell types, states and molecular programs in Appendiceal Cancer.
$50,000 Awarded to
Rivals United
Grant
Amar Kishan, MD
Name of Research Project:
The Radiographic, Transcriptomic, and Proteomic Foundations of Radiorecurrent Prostate Cancer.
$100,000 Awarded to
Medical Advisory Board Fellowship Grant
Dr. Giovanni E. Cacciamani, MD, MSc, FEBU
Name of Research Project:
The correlation between urinary bacteria diversity and tumorigenesis of kidney cancer.
$150,000 Awarded to
Barry Hoeven Memorial Grant
Roshan M. Patel, MD
Name of Research Project:
A Radiomic-Based Machine Learning Algorithm to Reliably Predict Vascular Wall Invasion of The Inferior Vena Cava in Patients with Renal Cell Carcinoma and Tumor Thrombus.
$250,000 Awarded to